Skip to main content
Krka logo

Krka — Investor Relations & Filings

Ticker · KRKG ISIN · SI0031102120 LEI · 549300H9RLRTRTLRUZ73 LJSE Manufacturing
Open in API
Filings indexed 1,887 across all filing types
Latest filing 2018-12-24 Transaction in Own Shar…
Country SI Slovenia
Listing LJSE KRKG

About Krka

https://www.krka.biz/en/

Krka is an international generic pharmaceutical company engaged in the development, production, marketing, and sales of human and animal health products. The company's core business is focused on generic prescription pharmaceuticals, which it markets under its own brands. Its product portfolio is complemented by a range of non-prescription products and a comprehensive line of animal health products. With a history spanning over 70 years, Krka is committed to providing high-quality, effective, and safe products to a global market, aiming to contribute to a better quality of life.

Recent filings

Filing Released Lang Actions
Pridobivanje lastnih delnic
Transaction in Own Shares Classification · 100% confidence The document text is in Slovenian and explicitly states its category as 'Pridobitev in odsvojitev izdajateljevih lastnih delnic' (Acquisition and disposal of the issuer's own shares). The content details the specific number of own shares repurchased by KRKA, d. d., Novo mesto, over several days in December 2018, including transaction dates, quantities, and average prices. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchases.
2018-12-24 Slovene
Acquisition of treasury shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its category as 'Acquisition or disposal of the issuer's own shares' and details the 'Acquisition of treasury shares' by Krka, d. d., Novo mesto, including specific transaction dates (December 7 to December 14, 2018) and the resulting change in the total number of treasury shares. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchase or issuance activities.
2018-12-18 English
Pridobivanje lastnih delnic
Transaction in Own Shares Classification · 100% confidence The document text is in Slovenian and its category is explicitly stated as 'Pridobitev in odsvojitev izdajateljevih lastnih delnic' (Acquisition and disposal of the issuer's own shares). The content details the number of own shares repurchased by KRKA, d. d., Novo mesto during a specific period (December 7 to December 14, 2018), including transaction dates, quantities, and average prices. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchases. The document is a specific report detailing these transactions, not merely an announcement of a report's publication (RPA) or a general regulatory filing (RNS).
2018-12-18 Slovene
Decision by the European Commission regarding perindopril
Legal Proceedings Report Classification · 99% confidence The document is a formal announcement from KRKA, d. d., Novo mesto, categorized as 'Inside information' and published via SEOnet. It details a specific legal/regulatory event: a Judgement from the General Court of the EU regarding a fine imposed by the European Commission concerning perindopril competition rules. This concerns a significant legal matter involving the company and regulatory bodies. This fits best under 'Legal Proceedings Report' (LTR), as it is an update on a significant lawsuit/regulatory action. It is not an earnings release, annual report, or a simple announcement of a report publication (RPA), but rather the substance of a legal decision affecting the company.
2018-12-13 English
Odločitev Komisije EU v zadevi perindopril
Legal Proceedings Report Classification · 99% confidence The document is a short announcement from KRKA, d. d., Novo mesto, dated 12. 12. 2018, regarding a legal decision ('Odločitev Komisije EU v zadevi perindopril') from the General Court of the EU concerning an antitrust fine. It explicitly mentions informing the public according to Article 17 of Regulation (EU) No 596/2014 (MAR). This type of communication, detailing a significant legal outcome or regulatory action, fits best under the 'Legal Proceedings Report' (LTR) category, as it is an update on a significant lawsuit/regulatory matter. It is too specific for the general 'Regulatory Filings' (RNS) fallback, and it is not a full report, presentation, or earnings release. Given the content focuses entirely on a legal/regulatory dispute resolution, LTR is the most appropriate classification.
2018-12-13 Slovene
Financial Calendar 2019
Report Publication Announcement Classification · 95% confidence The document provided is explicitly titled "FINANCIAL CALENDAR FOR 2019" and lists scheduled dates for various corporate events, including the release of financial statements, press conferences, AGM notices, and dividend proposals. It is not the actual financial report, AGM presentation, or management discussion itself, but rather an announcement detailing *when* these reports and events will occur. Specifically, it announces the 'Release of 2018 Annual Report', 'Release of January – March 2019 Interim Report', '25th Annual General Meeting Notice', and 'Release of 25th Annual General Meeting Resolutions'. Since the document's primary function is to announce the timing of future corporate publications and meetings, it fits best under the category for announcing report publications or general regulatory updates. Given the specific nature of announcing the schedule for reports and meetings, 'Report Publication Announcement' (RPA) is the most precise fit, as it announces the publication schedule for multiple reports (Annual Report, Interim Reports) and the AGM. It is not the report itself (10-K or IR), nor is it a transcript (CT) or a dividend notice (DIV), but a schedule for all of them.
2018-12-12 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.